Publications
34
Citations
1,047
Est. group size
—
Recurring co-author estimate
Active years
11
Publishing since 2016
Bikash Chandra Jena's research focuses on cancer biology, particularly how tumors resist chemotherapy and progress, with attention to processes like autophagy (a cell recycling mechanism), TGF-β signaling, and the role of supportive cells around tumors called cancer-associated fibroblasts. This work spans breast cancer, glioblastoma (a brain cancer), and drug delivery approaches such as nanoparticle-based and light-responsive drug carriers designed to target cancer cells more effectively.
Publication output was highest around 2018-2021 and has notably slowed in more recent years (2023-2025), with only one to two papers per year.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Foreword
Elsevier eBooks · 2026
- PSMC2 promotes resistance against temozolomide in glioblastoma via suppressing JNK-mediated autophagic cell death
Biochemical Pharmacology · 2025
- Redox‐Responsive Core Cross‐Linked Micelle as Anticancer Drug Delivery Vehicle
Journal of Applied Polymer Science · 2025
- Biochemical pharmacology of adenylyl cyclases in cancer
Biochemical Pharmacology · 2024
- A novel computational predictive biological approach distinguishes Integrin β1 as a salient biomarker for breast cancer chemoresistance
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2023
- TGF-β1 induced autophagy in cancer associated fibroblasts during hypoxia contributes EMT and glycolysis via MCT4 upregulation
Experimental Cell Research · 2022
- Understanding the function and regulation of Sox2 for its therapeutic potential in breast cancer
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2022
- A two-photon responsive hydroxyphenylquinazolinone (HPQ)-based fluorescent organic nanoprodrug for H <sub>2</sub> S release against oxidative stress
Chemical Communications · 2022
- TGF-β1 Induced Autophagy in Cancer Associated Fibroblasts During Hypoxia Contributes EMT and Glycolysis Via MCT4 Upregulation
SSRN Electronic Journal · 2022
- The transformation of cancer-associated fibroblasts: Current perspectives on the role of TGF-β in CAF mediated tumor progression and therapeutic resistance
Cancer Letters · 2021
- Paracrine TGF-β1 from breast cancer contributes to chemoresistance in cancer associated fibroblasts via upregulation of the p44/42 MAPK signaling pathway
Biochemical Pharmacology · 2021
- Screening of the Prime bioactive compounds from Aloe vera as potential anti-proliferative agents targeting DNA
Computers in Biology and Medicine · 2021
- Active autophagy in cancer‐associated fibroblasts: Recent advances in understanding the novel mechanism of tumor progression and therapeutic response
Journal of Cellular Physiology · 2021
- Synthesis, self-assembly and drug release study of a new dual-responsive biocompatible block copolymer containing phenylalanine derivative
Journal of Macromolecular Science Part A · 2021
- Cancer associated fibroblast mediated chemoresistance: A paradigm shift in understanding the mechanism of tumor progression
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2020
- Cancer Research×4
- Biochimica et Biophysica Acta (BBA) - Reviews on Cancer×3
- Biochemical Pharmacology×3
- Elsevier eBooks×3
- New Biotechnology×2
- Zhe Li
Medicine · Purdue University West Lafayette
- Seung-Oe Lim
Medicine · Purdue University West Lafayette
- Qi-En Wang
Medicine · The Ohio State University
- Sarah Steck
Medicine · The Ohio State University
- Briana To
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 20, 2026.
Claim or correct this profile